The term “6H syndrome” has been coined to explain the constellation of biochemical changes seen after i.v. iron infusion: high FGF23, hyperphosphaturia, hypophosphatemia, hypovitaminosis D, hypocalcemia, and secondary hyperparathyroidism.1 Here, FGF23 is linked to secondary hyperparathyroidism.